Interferons are proteins your cells release when they detect a virus, acting as an alarm system that warns neighboring cells to prepare their defenses. Nearly every cell in your body can produce interferons, making them one of the earliest and most widespread weapons in your immune response. Once released, these signaling molecules trigger a cascade of protective changes in surrounding cells that can slow or stop a virus from spreading.
How Interferons Work
When a virus enters one of your cells, that cell recognizes the threat and begins pumping out interferons. These proteins travel to neighboring cells, both infected and uninfected, and latch onto specific receptors on their surfaces. That binding event kicks off a chain reaction inside the cell: proteins called JAK and STAT get activated in sequence, ultimately forming a complex that moves into the cell’s nucleus and switches on dozens of protective genes.
The proteins produced by those genes are the real workhorses. Some, like PKR, shut down the cell’s protein-making machinery so the virus can’t use it to copy itself. Others, like the OAS family of proteins, activate enzymes that chop up viral genetic material directly. Another protein called viperin disrupts viral replication through a different mechanism, and a protein known as ZAP is particularly effective against retroviruses and certain other viral families. Together, these defenses put the cell into what researchers call an “antiviral state,” a kind of lockdown that makes it far harder for a virus to hijack the cell’s resources.
The Three Types of Interferons
Interferons come in three families, each with a different job and different cellular origins.
Type I (alpha and beta): This is the largest family and the first line of antiviral defense. Humans have 13 subtypes of interferon-alpha alone, plus interferon-beta and a few rarer members. Type I interferons were the first to be discovered, back in 1957, based on their ability to block viral infection. They’re also involved in slowing cell growth and fine-tuning the broader immune response. Specialized immune cells called plasmacytoid dendritic cells are major producers of interferon-alpha, though most cell types can release type I interferons when infected.
Type II (gamma): This family has just one member, interferon-gamma, and it plays a very different role. Rather than directly fighting viruses, interferon-gamma is a powerful activator of macrophages, the immune cells that engulf and destroy pathogens. Natural killer cells and a related group called innate lymphoid cells are the primary producers during infection. Interferon-gamma dramatically amplifies macrophage responses to microbial threats. It does this in part by suppressing the cell’s own braking mechanisms, essentially removing the limits on how aggressively macrophages respond. This makes it critical for fighting bacteria and other pathogens that live inside cells, not just viruses.
Type III (lambda): The newest family to be discovered, with four subtypes in humans. Type III interferons specialize in protecting epithelial surfaces, the lining of your lungs, gut, and other tissues that face the outside world. They provide a front-line defense with less collateral damage than the more potent type I response. Think of them as a more targeted, lower-intensity alarm system for the tissues most likely to encounter pathogens first.
Interferon Therapy for Disease
Because interferons have antiviral, anti-tumor, and immune-modulating properties, synthetic versions have been developed as medications. The most established use is in multiple sclerosis. Interferon beta was the first disease-modifying therapy available for MS, and five formulations are currently approved for relapsing forms of the disease. These medications reduce relapse rates and delay the progression of disability. They remain a standard first-line treatment option.
Interferon-alpha has been used to treat certain cancers and was for years a cornerstone of hepatitis B and hepatitis C treatment. For hepatitis C specifically, newer direct-acting antiviral drugs have largely replaced interferon-based regimens because they work faster with fewer side effects. Interferon-alpha remains in use for some other conditions where its immune-stimulating and anti-proliferative effects are beneficial.
Why Interferon Treatment Feels Like the Flu
One of the most common complaints from people receiving interferon therapy is that it feels like coming down with the flu: headache, muscle aches, sweating, and fatigue. This isn’t a coincidence. The flu-like symptoms you experience during an actual viral infection are largely caused by your body’s own interferons doing their job. When you inject synthetic interferons as medicine, you’re essentially triggering that same inflammatory alarm without the virus. Your body responds as though it’s fighting an infection because, at the molecular level, it’s receiving the same signal. These symptoms are typically managed with over-the-counter pain and fever medications and often become less intense over time as the body adjusts.
Interferons as a Diagnostic Tool
Interferon-gamma also has a role in diagnosing disease, most notably tuberculosis. The interferon-gamma release assay, commonly called IGRA, is a blood test that exploits a simple principle: if you’ve been infected with TB bacteria, certain white blood cells in your blood will “remember” that encounter. When a blood sample is mixed with proteins that mimic TB antigens, those primed white blood cells release interferon-gamma in response. The test measures either the total amount of interferon-gamma released or the number of cells producing it.
This immune memory typically develops within six to eight weeks of TB infection. The TB proteins used in the test were specifically chosen because they’re found in the TB bacterium but absent from the BCG vaccine and most other related bacteria, which means the test can distinguish between actual TB infection and prior vaccination. A positive result usually indicates TB infection, though additional testing determines whether the infection is active or latent.